What is KLOW?
KLOW is a four-peptide co-formulated research blend designed for comparative biochemical investigation of structurally distinct peptide compounds in a single co-packaged preparation. It is intended strictly for laboratory and research purposes.
Blend Composition (Component Analysis)
OP-GHK-Cu — 50mg
Structure: Tripeptide-copper(II) coordination complex (Gly-His-Lys · Cu²⁺)
Amino acids: 3 residues | MW (complex): ~402.9 Da
Coordination: Square-planar Cu(II) chelate with high affinity (Kd ~10⁻¹⁵ M)
Research application: Coordination chemistry, Cu(II) binding kinetics, gene expression pathway studies
TB-500 — 10mg
Structure: 17-amino-acid synthetic fragment of thymosin beta-4 (Tβ4); actin-binding region
Amino acids: 17 residues | MW: ~2,114.4 Da (acetate salt)
Research application: Actin-binding kinetics, cytoskeletal interaction studies, Tβ4 fragment comparative research
BPC-157 — 10mg
Structure: 15-amino-acid pentadecapeptide derived from gastric juice protein BPC sequence
Amino acids: 15 residues | MW: ~1,419.5 Da
Research application: Nitric oxide signaling pathway research, structural stability studies, comparative gastric peptide research
KPV — 10mg
Structure: Tripeptide (Lys-Pro-Val); C-terminal fragment of alpha-melanocyte-stimulating hormone (α-MSH)
Amino acids: 3 residues | MW: ~340.4 Da
Research application: MC receptor fragment pharmacology, α-MSH C-terminal fragment comparative studies
Regulatory & Research Context
KLOW is sold strictly for in vitro research and laboratory use only. It is not intended for human or veterinary use, consumption, or application of any kind. It is not approved by the FDA to diagnose, treat, cure, or prevent any disease or condition. Not for use in any living organism.
Scientific References
- Pickart L, Margolina A. International Journal of Molecular Sciences. 2018.
- Goldstein AL, et al. Annals of the New York Academy of Sciences. 2012.
- Sikiric P, et al. Current Pharmaceutical Design. 2010.
- PubMed: PMC6164879 | PMC3535097 | PMC8388779
VIALS
